TY  - GEN
AU  - Kelly,Louise M
AU  - Yu,Jin-Chen
AU  - Boulton,Christina L
AU  - Apatira,Mutiah
AU  - Li,Jason
AU  - Sullivan,Carol M
AU  - Williams,Ifor
AU  - Amaral,Sonia M
AU  - Curley,David P
AU  - Duclos,Nicole
AU  - Neuberg,Donna
AU  - Scarborough,Robert M
AU  - Pandey,Anjali
AU  - Hollenbach,Stanley
AU  - Abe,Keith
AU  - Lokker,Nathalie A
AU  - Gilliland,D Gary
AU  - Giese,Neill A
TI  - CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
SN  - 1535-6108
PY  - 2002///0927
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Bone Marrow Cells
KW  - enzymology
KW  - Bone Marrow Transplantation
KW  - Enzyme Inhibitors
KW  - Flow Cytometry
KW  - Humans
KW  - Immunoblotting
KW  - Interleukin-3
KW  - metabolism
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Mutation
KW  - Phosphorylation
KW  - Piperazines
KW  - Proto-Oncogene Proteins
KW  - antagonists & inhibitors
KW  - Proto-Oncogene Proteins c-kit
KW  - Quinazolines
KW  - Receptor Protein-Tyrosine Kinases
KW  - Receptors, Cell Surface
KW  - Receptors, Platelet-Derived Growth Factor
KW  - Tandem Repeat Sequences
KW  - Transfection
KW  - Tumor Cells, Cultured
KW  - fms-Like Tyrosine Kinase 3
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1016/s1535-6108(02)00070-3
ER  -